MARKET INTRODUCTION
Anti-aging drugs are utilized for slowing down or reversing the process of aging in order to extend the lifespan and to look younger. The process of aging, leads to damage in the body's cells, macromolecules, tissues a variety of ways such as epigenetic alterations, genetic instability, loss of proteostasis, mitochondrial dysfunction, stem cell exhaustion, oxidative damage by free radicals etc. Anti-aging drugs often include different minerals, natural and synthetically derived products.
MARKET DYNAMICS
The key market drivers for Anti-Ageing Drugs Market Includes, increasing ageing population across the globe along with rising demand for anti-aging and cosmetic products. Moreover, influence of digital platforms such as social media, film and fashion industry to look young and healthy is also expected to fuel market growth during the forecast period. However, stringent regulations for anti- ageing preparations along with possible side effects after prolonged use of them is expected to restrain market growth during the forecast period.
MARKET SCOPE
The "Anti-Ageing Drugs Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Anti-Ageing Drugs market with detailed market segmentation by type, drug class and application. The Anti-Ageing Drugs Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Anti-Ageing Drugs Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Anti-Ageing Drugs Market is segmented on the basis of type, drug class and application. On the basis of type the market is segmented as, injectable, oral, and topical. On the basis of drug class the market is segmented as, antioxidants and enzymes, serum and supplements and stem cells. And on the basis of applications the market is segmented as, skin, hair, muscles, age related disorders and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Anti-Ageing Drugs Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Anti-Ageing Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Anti-Ageing Drugs Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Anti-Ageing Drugs Market in these regions.
MARKET PLAYERS
The report covers key developments in the Anti-Ageing Drugs Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Anti-Ageing Drugs Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Anti-Ageing Drugs market in the global market. Below mentioned is the list of few companies engaged in the Anti-Ageing Drugs Market.
The report also includes the profiles of key players in Anti-Ageing Drugs Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
Galderma
Sanofi
Allergan
Daewoong Pharmaceuticals
Revitacare
Merz Pharma
Nu Skin
BIOTIME, INC.
Elysium Health Inc.
La Roche- Posay
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti-Ageing Drugs Market - By Type
1.3.2 Anti-Ageing Drugs Market - By Drug Class
1.3.3 Anti-Ageing Drugs Market - By Applications
1.3.4 Anti-Ageing Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTI-AGEING DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTI-AGEING DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTI-AGEING DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI-AGEING DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTI-AGEING DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTI-AGEING DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. INJECTABLE
7.3.1. Overview
7.3.2. Injectable Market Forecast and Analysis
7.4. ORAL
7.4.1. Overview
7.4.2. Oral Market Forecast and Analysis
7.5. TOPICAL
7.5.1. Overview
7.5.2. Topical Market Forecast and Analysis
8. ANTI-AGEING DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
8.1. OVERVIEW
8.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
8.3. ANTIOXIDANTS AND ENZYMES
8.3.1. Overview
8.3.2. Antioxidants and enzymes Market Forecast and Analysis
8.4. SERUMS AND SUPPLEMENTS
8.4.1. Overview
8.4.2. Serums and supplements Market Forecast and Analysis
8.5. STEM CELLS
8.5.1. Overview
8.5.2. Stem cells Market Forecast and Analysis
9. ANTI-AGEING DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
9.1. OVERVIEW
9.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
9.3. SKIN
9.3.1. Overview
9.3.2. Skin Market Forecast and Analysis
9.4. HAIR
9.4.1. Overview
9.4.2. Hair Market Forecast and Analysis
9.5. MUSCLES
9.5.1. Overview
9.5.2. Muscles Market Forecast and Analysis
9.6. AGE-RELATED DISORDERS
9.6.1. Overview
9.6.2. Age-related disorders Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. ANTI-AGEING DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Anti-Ageing Drugs Market Overview
10.1.2 North America Anti-Ageing Drugs Market Forecasts and Analysis
10.1.3 North America Anti-Ageing Drugs Market Forecasts and Analysis - By Type
10.1.4 North America Anti-Ageing Drugs Market Forecasts and Analysis - By Drug Class
10.1.5 North America Anti-Ageing Drugs Market Forecasts and Analysis - By Applications
10.1.6 North America Anti-Ageing Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Anti-Ageing Drugs Market
10.1.6.1.1 United States Anti-Ageing Drugs Market by Type
10.1.6.1.2 United States Anti-Ageing Drugs Market by Drug Class
10.1.6.1.3 United States Anti-Ageing Drugs Market by Applications
10.1.6.2 Canada Anti-Ageing Drugs Market
10.1.6.2.1 Canada Anti-Ageing Drugs Market by Type
10.1.6.2.2 Canada Anti-Ageing Drugs Market by Drug Class
10.1.6.2.3 Canada Anti-Ageing Drugs Market by Applications
10.1.6.3 Mexico Anti-Ageing Drugs Market
10.1.6.3.1 Mexico Anti-Ageing Drugs Market by Type
10.1.6.3.2 Mexico Anti-Ageing Drugs Market by Drug Class
10.1.6.3.3 Mexico Anti-Ageing Drugs Market by Applications
10.2. EUROPE
10.2.1 Europe Anti-Ageing Drugs Market Overview
10.2.2 Europe Anti-Ageing Drugs Market Forecasts and Analysis
10.2.3 Europe Anti-Ageing Drugs Market Forecasts and Analysis - By Type
10.2.4 Europe Anti-Ageing Drugs Market Forecasts and Analysis - By Drug Class
10.2.5 Europe Anti-Ageing Drugs Market Forecasts and Analysis - By Applications
10.2.6 Europe Anti-Ageing Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Anti-Ageing Drugs Market
10.2.6.1.1 Germany Anti-Ageing Drugs Market by Type
10.2.6.1.2 Germany Anti-Ageing Drugs Market by Drug Class
10.2.6.1.3 Germany Anti-Ageing Drugs Market by Applications
10.2.6.2 France Anti-Ageing Drugs Market
10.2.6.2.1 France Anti-Ageing Drugs Market by Type
10.2.6.2.2 France Anti-Ageing Drugs Market by Drug Class
10.2.6.2.3 France Anti-Ageing Drugs Market by Applications
10.2.6.3 Italy Anti-Ageing Drugs Market
10.2.6.3.1 Italy Anti-Ageing Drugs Market by Type
10.2.6.3.2 Italy Anti-Ageing Drugs Market by Drug Class
10.2.6.3.3 Italy Anti-Ageing Drugs Market by Applications
10.2.6.4 Spain Anti-Ageing Drugs Market
10.2.6.4.1 Spain Anti-Ageing Drugs Market by Type
10.2.6.4.2 Spain Anti-Ageing Drugs Market by Drug Class
10.2.6.4.3 Spain Anti-Ageing Drugs Market by Applications
10.2.6.5 United Kingdom Anti-Ageing Drugs Market
10.2.6.5.1 United Kingdom Anti-Ageing Drugs Market by Type
10.2.6.5.2 United Kingdom Anti-Ageing Drugs Market by Drug Class
10.2.6.5.3 United Kingdom Anti-Ageing Drugs Market by Applications
10.2.6.6 Rest of Europe Anti-Ageing Drugs Market
10.2.6.6.1 Rest of Europe Anti-Ageing Drugs Market by Type
10.2.6.6.2 Rest of Europe Anti-Ageing Drugs Market by Drug Class
10.2.6.6.3 Rest of Europe Anti-Ageing Drugs Market by Applications
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Anti-Ageing Drugs Market Overview
10.3.2 Asia-Pacific Anti-Ageing Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Anti-Ageing Drugs Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Anti-Ageing Drugs Market Forecasts and Analysis - By Drug Class
10.3.5 Asia-Pacific Anti-Ageing Drugs Market Forecasts and Analysis - By Applications
10.3.6 Asia-Pacific Anti-Ageing Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Anti-Ageing Drugs Market
10.3.6.1.1 Australia Anti-Ageing Drugs Market by Type
10.3.6.1.2 Australia Anti-Ageing Drugs Market by Drug Class
10.3.6.1.3 Australia Anti-Ageing Drugs Market by Applications
10.3.6.2 China Anti-Ageing Drugs Market
10.3.6.2.1 China Anti-Ageing Drugs Market by Type
10.3.6.2.2 China Anti-Ageing Drugs Market by Drug Class
10.3.6.2.3 China Anti-Ageing Drugs Market by Applications
10.3.6.3 India Anti-Ageing Drugs Market
10.3.6.3.1 India Anti-Ageing Drugs Market by Type
10.3.6.3.2 India Anti-Ageing Drugs Market by Drug Class
10.3.6.3.3 India Anti-Ageing Drugs Market by Applications
10.3.6.4 Japan Anti-Ageing Drugs Market
10.3.6.4.1 Japan Anti-Ageing Drugs Market by Type
10.3.6.4.2 Japan Anti-Ageing Drugs Market by Drug Class
10.3.6.4.3 Japan Anti-Ageing Drugs Market by Applications
10.3.6.5 South Korea Anti-Ageing Drugs Market
10.3.6.5.1 South Korea Anti-Ageing Drugs Market by Type
10.3.6.5.2 South Korea Anti-Ageing Drugs Market by Drug Class
10.3.6.5.3 South Korea Anti-Ageing Drugs Market by Applications
10.3.6.6 Rest of Asia-Pacific Anti-Ageing Drugs Market
10.3.6.6.1 Rest of Asia-Pacific Anti-Ageing Drugs Market by Type
10.3.6.6.2 Rest of Asia-Pacific Anti-Ageing Drugs Market by Drug Class
10.3.6.6.3 Rest of Asia-Pacific Anti-Ageing Drugs Market by Applications
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Anti-Ageing Drugs Market Overview
10.4.2 Middle East and Africa Anti-Ageing Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Anti-Ageing Drugs Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Anti-Ageing Drugs Market Forecasts and Analysis - By Drug Class
10.4.5 Middle East and Africa Anti-Ageing Drugs Market Forecasts and Analysis - By Applications
10.4.6 Middle East and Africa Anti-Ageing Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Anti-Ageing Drugs Market
10.4.6.1.1 South Africa Anti-Ageing Drugs Market by Type
10.4.6.1.2 South Africa Anti-Ageing Drugs Market by Drug Class
10.4.6.1.3 South Africa Anti-Ageing Drugs Market by Applications
10.4.6.2 Saudi Arabia Anti-Ageing Drugs Market
10.4.6.2.1 Saudi Arabia Anti-Ageing Drugs Market by Type
10.4.6.2.2 Saudi Arabia Anti-Ageing Drugs Market by Drug Class
10.4.6.2.3 Saudi Arabia Anti-Ageing Drugs Market by Applications
10.4.6.3 U.A.E Anti-Ageing Drugs Market
10.4.6.3.1 U.A.E Anti-Ageing Drugs Market by Type
10.4.6.3.2 U.A.E Anti-Ageing Drugs Market by Drug Class
10.4.6.3.3 U.A.E Anti-Ageing Drugs Market by Applications
10.4.6.4 Rest of Middle East and Africa Anti-Ageing Drugs Market
10.4.6.4.1 Rest of Middle East and Africa Anti-Ageing Drugs Market by Type
10.4.6.4.2 Rest of Middle East and Africa Anti-Ageing Drugs Market by Drug Class
10.4.6.4.3 Rest of Middle East and Africa Anti-Ageing Drugs Market by Applications
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Anti-Ageing Drugs Market Overview
10.5.2 South and Central America Anti-Ageing Drugs Market Forecasts and Analysis
10.5.3 South and Central America Anti-Ageing Drugs Market Forecasts and Analysis - By Type
10.5.4 South and Central America Anti-Ageing Drugs Market Forecasts and Analysis - By Drug Class
10.5.5 South and Central America Anti-Ageing Drugs Market Forecasts and Analysis - By Applications
10.5.6 South and Central America Anti-Ageing Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Anti-Ageing Drugs Market
10.5.6.1.1 Brazil Anti-Ageing Drugs Market by Type
10.5.6.1.2 Brazil Anti-Ageing Drugs Market by Drug Class
10.5.6.1.3 Brazil Anti-Ageing Drugs Market by Applications
10.5.6.2 Argentina Anti-Ageing Drugs Market
10.5.6.2.1 Argentina Anti-Ageing Drugs Market by Type
10.5.6.2.2 Argentina Anti-Ageing Drugs Market by Drug Class
10.5.6.2.3 Argentina Anti-Ageing Drugs Market by Applications
10.5.6.3 Rest of South and Central America Anti-Ageing Drugs Market
10.5.6.3.1 Rest of South and Central America Anti-Ageing Drugs Market by Type
10.5.6.3.2 Rest of South and Central America Anti-Ageing Drugs Market by Drug Class
10.5.6.3.3 Rest of South and Central America Anti-Ageing Drugs Market by Applications
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTI-AGEING DRUGS MARKET, KEY COMPANY PROFILES
12.1. GALDERMA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SANOFI
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ALLERGAN
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. DAEWOONG PHARMACEUTICALS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. REVITACARE
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERZ PHARMA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NU SKIN
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BIOTIME, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ELYSIUM HEALTH INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. LA ROCHE-POSAY
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11. DERMAFIX
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
12.12. L'OR
The List of Companies
1. Galderma
2. Sanofi
3. Allergan
4. Daewoong Pharmaceuticals
5. Revitacare
6. Merz Pharma
7. Nu Skin
8. BIOTIME, INC.
9. Elysium Health Inc.
10. La Roche-Posay
11. DermaFix
12. L'OR
Global Soft Mist Inhaler Market Report -..
This report elaborates the market size, market characteris..
+1-646-791 7070US (Toll Free)